The ayahuasca vine contains harmala alkaloids, not DMT — which is why it is not a federally scheduled substance in the US, and why that changes the moment it is brewed with a DMT-containing plant.
Ayahuasca is a two-plant preparation. Banisteriopsis caapi — the woody vine sometimes called yagé, caapi, or simply "the vine" — supplies the harmala alkaloids (harmine, harmaline, tetrahydroharmine), which are reversible inhibitors of monoamine oxidase A. A second plant, usually Psychotria viridis (chacruna) or Diplopterys cabrerana, supplies the N,N-DMT. The MAOI keeps the DMT from being broken down in the gut, which is what makes the brew orally active.
US drug law schedules substances, not traditions. DMT has been Schedule I since the Controlled Substances Act took effect in 1971. Harmine, harmaline, and tetrahydroharmine are not listed in any federal schedule — not Schedule I, not Schedule V, not as listed chemicals. So the two halves of the same brew sit on opposite sides of federal law, and the vine on its own is in the same broad category as any other unscheduled botanical.
Yes — the vine itself is not a federally controlled substance. Live plants, cuttings, seeds, and dried vine are sold openly by US ornamental-plant nurseries, and no federal schedule reaches them. There is no DEA registration requirement to own the plant.
Two caveats are worth stating plainly, because they are where people actually get into trouble:
The vine is unscheduled. The moment it is combined with a DMT-containing plant, the resulting preparation contains a Schedule I controlled substance and is treated as such — the plant it came from is irrelevant to that analysis. Possessing, brewing, transporting, or importing ayahuasca is a federal offense unless you are a member of a religious organization holding a DEA exemption. See where DMT is legal for the exemption list and the state picture.
Almost every state schedules controlled substances by reference to the federal list, which means an unscheduled plant stays unscheduled at state level too. Louisiana is the outlier, and it is the one state answer worth knowing in detail.
Louisiana Act 159 of 2005, codified at La. R.S. 40:989.1, names roughly forty "hallucinogenic plants," including Banisteriopsis spp. The prohibition is narrower than it is usually reported to be. The statute makes it unlawful to knowingly or intentionally produce, manufacture, distribute, or possess with intent to produce, manufacture, or distribute "a material, compound, mixture, or preparation intended for human consumption" containing a listed plant. It carves out three exceptions: plants grown strictly for aesthetic, landscaping, or decorative purposes; FDA-recognized non-prescription homeopathic drugs; and dietary supplements compliant with the federal Food, Drug, and Cosmetic Act. Penalties run to 2–10 years and a fine of up to $20,000 for distribution or manufacture.
In practical terms: a caapi vine on a Louisiana trellis is exempt as an ornamental. The same vine cut up and prepared as a drinkable brew is what the statute is aimed at.
| Jurisdiction | Status of the vine / harmala alkaloids | What that means in practice |
|---|---|---|
| US — federal | Not scheduled. Harmine, harmaline, and THH are absent from the CSA schedules. | Owning, growing, and selling the plant is lawful. Any DMT-containing preparation is Schedule I. |
| US — Louisiana | Banisteriopsis spp. listed under La. R.S. 40:989.1. | Preparing or distributing it for human consumption is a felony. Ornamental cultivation is expressly exempt. |
| US — Colorado | Vine unscheduled; DMT personal possession decriminalized under Prop 122. | The vine was never the issue in Colorado; the Natural Medicine Health Act changed the DMT half of the analysis for adults 21+. |
| United Kingdom | Harmala alkaloids are not in the Misuse of Drugs Act 1971, but the Psychoactive Substances Act 2016 applies. | Production, supply, and import are offenses. Simple possession is not an offense outside custodial institutions. |
| Australia | Harmala alkaloids are Schedule 9 (Prohibited Substances) in the Poisons Standard. | Manufacture, possession, sale, and use are prohibited except for approved research or analytical purposes. Australia is materially stricter than the US here. |
It is pharmacologically active, but it is not a classical hallucinogen. Taken alone, caapi acts principally as a reversible MAO-A inhibitor; users of vine-only preparations typically describe sedation, nausea, purging, and at higher amounts a dreamy or tremulous state — not the visionary effects the brew is known for. Those come from the DMT admixture. This distinction matters legally as well as experientially: it is the reason the vine has never attracted a federal schedule of its own.
The MAOI pharmacology that makes caapi legally uninteresting is exactly what makes it medically risky. Monoamine oxidase inhibition is one of the most interaction-heavy mechanisms in pharmacology:
This page is a legal reference. It is not a preparation, sourcing, or dosing guide, and nothing here should be read as encouragement to make or consume a psychoactive preparation.
Yes. The vine contains harmine, harmaline, and tetrahydroharmine — none of which appear on the federal Controlled Substances Act schedules — so it is not a federally controlled substance, and live plants, cuttings, and seeds are sold openly as ornamentals. Louisiana is the one clear state exception: La. R.S. 40:989.1 lists Banisteriopsis spp. and prohibits preparing it for human consumption, while expressly exempting plants grown for aesthetic, landscaping, or decorative purposes.
No, and the difference is the whole legal question. Banisteriopsis caapi is the vine, and it supplies MAOI harmala alkaloids. Ayahuasca is the brew, which adds a DMT-containing plant such as Psychotria viridis. DMT is Schedule I, so the brew is a federally controlled substance even though the vine on its own is not.
It is pharmacologically active but not a classical hallucinogen. On its own the vine acts mainly as a reversible MAO-A inhibitor; vine-only preparations are typically described as sedating, nauseating, and purgative rather than visionary. The visionary effects of ayahuasca come from the DMT-containing admixture plant, not the vine.
No reported federal prosecution has treated the caapi vine as a controlled substance analogue. The Analogue Act reaches substances substantially similar in structure and effect to a scheduled drug and intended for human consumption; harmala alkaloids are beta-carboline MAO inhibitors, a different structural class and pharmacology from the scheduled tryptamine hallucinogens.
Both are stricter than the US. In the UK, harmala alkaloids are not in the Misuse of Drugs Act 1971, but the Psychoactive Substances Act 2016 makes production, supply, and import offenses — simple possession is not an offense outside custodial institutions. In Australia, harmala alkaloids are Schedule 9 prohibited substances under the Poisons Standard, so manufacture, possession, sale, and use are prohibited outside approved research.
Legality is not a safety clearance. Caapi is a monoamine oxidase inhibitor, and MAO inhibition is one of the most interaction-heavy mechanisms in pharmacology. Combined with SSRIs, SNRIs, tricyclics, lithium, triptans, tramadol, or MDMA it can cause serotonin syndrome, which can be fatal; with tyramine-rich foods such as aged cheese and cured meats it can cause a hypertensive reaction. It also raises blood pressure and carries psychiatric risk for people with a bipolar or psychosis history.
Get ayahuasca law research & policy updates
New trials, FDA decisions, and legal changes for ayahuasca law — delivered when they happen.
Suggest a tool, topic, or improvement that would make this site more useful.